News Updates
Scope

Tue, May 19, 2026

1 updates

Thu, May 7, 2026

1 updates

Fri, May 1, 2026

1 updates
VXRT
8:00 AM

Vaxart to Host Stockholder Fireside Chat on May 8 at 4:30 p.m. ET

Company to report first quarter 2026 financial results on May 7 SOUTH SAN FRANCISCO, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) today announced that members of the Company’s senior management team will participate in a virtual fireside chat on Friday, May 8, 2026 at 4:30

vaxart.com

Thu, Apr 23, 2026

1 updates
VXRT
4:30 PM

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors

Appointment strengthens Board’s clinical development and regulatory expertise as Vaxart advances its oral vaccine platform SOUTH SAN FRANCISCO, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral vaccines based on

vaxart.com

Fri, Apr 17, 2026

1 updates

Thu, Mar 12, 2026

1 updates

Tue, Mar 3, 2026

1 updates
VXRT
4:01 PM

Vaxart to Host Upcoming Conference Calls

Full year 2025 business update and financial results conference call to be held March 12 at 4:30 p.m. ET Stockholder fireside chat to be held on March 13 at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will host two

vaxart.com